Filter
23
Filtered Results: 23
Text search:
Nkhoma,
L.
et
all.
Featured
Recommendations
1
New Publications
9
Language
Document type
No document type
16
Studies & Reports
5
Guidelines
2
Countries / Regions
Malawi
7
Zambia
2
Africa
1
South–East Asia Region
1
Uganda
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
6
Studies & Reports
5
Drugs & Medical Equipment
2
Women & Child Health
2
Cervical Cancer
1
Public Health
1
Guidelines
1
Gynaecology & Obstetrics
1
Disease Prevention & Control
1
Reproductive Health
1
TB
1
Toolboxes
ART Drug Resistance
2
Children & Adolescents
2
Prevention of mother-to-child transmission (PMTCT)
2
Prevention & Control
1
Policies
1
Drug resistance
1
Ethiopia
1
Advocacy & Communication
1
Essential Medicines
1
Agriculture incl. animal husbandry
1
Taeniasis/Cysticercosis
1
Drug resistant TB
1
Uganda
1
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...
PLOS ONE | https://doi.org/10.1371/journal.pone.0217693 June 7, 2019
Malawi Integrated Guidelines and Standard Operating Procedures for Providing HIV Services. 3rd edition 2016
Journal of Infection and Public Health 12 (2019) 213–223
This document is written for medical doctors, clinical officers, medical assistants, nurses, midwives, health surveillance assistants (HSAs), and medical records clerks who are working in public and private sector health facilities in Malawi. It is designed to be a practical guide for implementation...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
guidance for health managers, health workers, and activists
Policy
July 2012
Working Paper No. 3
Antimicrobial Resistance and Infection Control 2014,3 :31
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
